Methods | Penicillin G % | Ciprofloxacin % | Ceftriaxone % | Tetracycline % | Spectinomycin % | Azithromycin % | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | S | I | R | |
Etest MIC | 08 | 49 | 43 | 00 | 14 | 86 | 100 | 00 | 00 | 12 | 37 | 51 | 100 | 00 | 00 | 99 | 00 | 01 |
CLSI/BSACa MIC break points (μg/ml) | ≤0.06 | 0.12-1 | ≥2 | ≤0.06 | 0.12-0.5 | ≥1 | ≤0.25 | - | - | ≤0.25 | 0.5–1 | ≥2 | ≤32 | 64 | ≥128 | ≤0.25 | 0.5 | ≥0.5 |
CDS disc diffusion | 10 | 13 | 77 | 00 | 20 | 80 | 100 | 00 | 00 | NP | NP | NP | 100 | 00 | 00 | 99 | 00 | 01 |
CDS annular radius break points (mm) | >9 | 3-9 | <3 | ≥11 | 6-10 | <6 | ≥10 | - | 5-9 | NP | NP | NP | ≥6 | - | <6 | ≥8 | - | <8 |
CLSI disc diffusion | 04 | 34 | 62 | 00 | 04 | 96 | 100 | 00 | 00 | 03 | 40 | 57 | 100 | 00 | 00 | 99 | 00 | 01 |
CLSI/BSACa zone diameter break points (mm) | ≥47 | 27-46 | ≤26 | >41 | 28-40 | ≤27 | ≥35 | - | - | ≥38 | 31-37 | <30 | ≥18 | 15-17 | ≤4 | ≥28 | - | ≤27 |